Ursodeoxycholic Acid Tablets in India serve as a prescribed treatment that doctors in India use to treat particular liver and biliary disorders. The substance functions as a natural bile acid, which enhances bile flow while protecting liver cells from damage and decreasing bile cholesterol levels.
Ursodeoxycholic Acid Tablets treat cholesterol gallstones and primary biliary cholangitis (PBC) and other cholestatic diseases through their therapeutic properties. UDCA improves bile secretion and supports liver function, and is sometimes prescribed in cases of fatty liver and bile acid malabsorption under medical supervision.
List of Top Ursodeoxycholic Acid Tablets in India
We have compiled a list of the Top Ursodeoxycholic Acid Tablet Brands that are marketed by top-rated pharma companies across the nation. Here we begin:
UDIZYX 150 Tablet
UDIZYX 150 Tablet functions as a UDCA medication, which medical professionals administer to treat patients with chronic liver conditions and bile acid disorders. The medication protects liver cells from toxic bile acid damage while helping to control bile flow, which results in better symptom management for patients with cholestatic disorders. It is one of the Ursodeoxycholic Acid Tablets in India. This formulation is often utilised for its hepatoprotective properties. The brand serves as a reliable option for managing conditions like primary biliary cirrhosis and associated liver inflammation.
Marketer: Kivonyx Healthcare
Composition: Ursodeoxycholic Acid (150 mg)
Packaging: 10×10 ALU-PVC Blister
UDIZYX 300 Tablet
UDIZYX 300 Tablet contains Ursodeoxycholic Acid and is prescribed for gallstone dissolution and liver protection. The medication decreases cholesterol levels in bile while simultaneously enhancing the complete operation of the liver. Doctors frequently prescribe this formulation to patients because it effectively supports their liver function during the treatment of cholestatic disorders and gallbladder stones. Its therapeutic profile makes it suitable for prolonged treatment courses when medically indicated. The product has a high demand in the pharma sector.
Marketer: Kivonyx Healthcare
Composition: Ursodeoxycholic Acid (300 mg)
Packaging: Blister strip (10×10)
Udiliv 600 Tablet
Udiliv 600 Tablet serves as a recognised medical treatment that doctors prescribe to enhance bile flow and treat liver diseases while using gallstone dissolving treatments. The drug provides a higher dose of UDCA, which doctors use to treat patients with intense medical needs who require better bile control. The tablet works by decreasing cholesterol levels in the bile, which leads to the gradual breakdown of cholesterol-based gallstones. The medical community supports this treatment because researchers studied how UDCA protects liver cells from destruction caused by toxic bile acids.
Marketer: Abbott Laboratories
Composition: Ursodeoxycholic Acid (600 mg)
Packaging: Blister strip (typically 10 tablets)
Ursokem 150 Tablet
Ursokem 150 Tablet is used to treat patients with liver and biliary disorders such as cholestatic disease and gallbladder stone management. The product helps improve bile secretion from the liver while decreasing cholesterol levels in bile to assist with nonsurgical management of gallstones. The brand is trusted in medical practice for consistent quality and patient tolerability. The treatment allows healthcare professionals to support liver function while decreasing bile acid-related harmful effects, which patients experience. The product comes in compact strips, which doctors recommend for their patients’ treatment periods.
Marketer: Alkem Laboratories Ltd
Composition: Ursodeoxycholic Acid (150 mg)
Packaging: Alu-Alu blister strip (10×10)
Hepakind 150 Tablet
Hepakind 150 Tablet from Mankind Pharma operates as a budget-friendly UDCA medication that people can easily obtain to treat liver conditions and biliary disorders. The medication helps improve bile production while safeguarding liver cells, which doctors prescribe for treating primary biliary cirrhosis and non-alcoholic fatty liver disease. The medication provides cost savings to both patients and doctors who need a trustworthy treatment option. The tablet format enables patients to take their medication according to their healthcare professional’s instructions. The brand maintains extensive distribution throughout Indian pharmacies.
Marketer: Mankind Pharma
Composition: Ursodeoxycholic Acid (150 mg)
Packaging: Alu-Alu blister strip (10×10)
Ulyses 150 Tablet
Ulyses 150 Tablet is another commonly used UDCA brand in India, valued for its quality manufacturing and dependable therapeutic outcome. The medication helps break down gallstones while it protects liver cells by decreasing cholesterol levels in bile and increasing bile acid production. The company follows GMP requirements with WHO standards to ensure its products meet safety guidelines and maintain quality. Physicians often recommend Ulyses for long-term liver support. The product comes in standard blister packs, which allow for convenient dispensing.
Marketer: Lupin Ltd.
Composition: Ursodeoxycholic Acid (150 mg)
Packaging: Blister strip (10×10)
Actibile 150 Tablet
Actibile 150 Tablet functions as a UDCA medication, which doctors prescribe to treat liver and biliary disorders. The medication uses Ursodeoxycholic Acid as its active ingredient, which helps patients by increasing bile flow while decreasing liver inflammation through bile acid regulation. Healthcare professionals trust Zydus Cadila because the company maintains strict quality standards. The drug serves as a treatment option for patients who experience chronic cholestatic conditions and require extended bile treatment. The product comes in a package that allows medical staff to dispense it in clinical settings.
Marketer: Zydus Cadila
Composition: Ursodeoxycholic Acid (150 mg)
Packaging: Alu-Alu blister strip (10×10)
UDIFIT 300 Tablet
UDIFIT 300 Tablet contains Ursodeoxycholic Acid, which helps patients with bile secretion and liver function. The medication treats primary biliary cholangitis and non-invasive cholesterol gallstone treatment. Aden Healthcare produces it in compliance with the WHO and DCGI standards, ensuring quality. The drug provides multiple dosage options that doctors can use to assess a patient’s liver condition. The healthcare provider recommended duration of treatment be extended through the use of blister-packaged medications.
Marketer: Aden Healthcare
Composition: Ursodeoxycholic Acid (300 mg)
Packaging: Blister strip (e.g., 5×3×15)
Conclusion
Ursodeoxycholic Acid Tablets in India are available to patients because leading pharma brands in India distribute their products through extensive distribution networks at affordable prices. The use of Ursodeoxycholic Acid requires a prescription, which patients must follow under medical supervision to receive proper dosage instructions, treatment length requirements and monitoring procedures. Better liver health and successful long-term control of biliary conditions depend on selecting a trustworthy brand while following a healthcare professional’s recommendations.
Frequently Asked Questions (FAQs)
Are Ursodeoxycholic Acid Tablets a profitable product for PCD Pharma Franchise in India?
Yes, Ursodeoxycholic Acid tablets have a strong demand due to rising liver disorders and gallstone cases. It is considered a high-potential product in the gastro and hepatology segment.
What investment is required to start a PCD franchise for Ursodeoxycholic Acid Tablets?
The initial investment usually ranges between ₹20,000 and ₹50,000, depending on company policies and stock quantity. It may vary based on product range and promotional support.
Which strengths of Ursodeoxycholic Acid are preferred for the PCD business?
Commonly demanded strengths in India include 150 mg, 300 mg, and 600 mg tablets. Higher strengths like 300 mg and 600 mg are often preferred in liver speciality practice.
Is DCGI approval mandatory for Ursodeoxycholic Acid PCD products?
Yes, Ursodeoxycholic Acid tablets must be DCGI-approved and manufactured in WHO-GMP certified facilities. Compliance ensures quality and legal distribution.
What documents are required to start UDCA PCD Pharma Franchise?
You need a valid Drug License number and GST registration to start a franchise business. Some companies may also require experience in pharma sales.
How is the market demand for Ursodeoxycholic Acid Tablets in India?
The demand is steadily increasing due to lifestyle-related liver diseases and gallstone issues. Gastroenterologists and physicians frequently prescribe UDCA formulations.
What margin can distributors expect in the Ursodeoxycholic Acid PCD business?
Profit margins generally range between 20% to 40%, depending on brand positioning and company policy. Monopoly rights can further improve profitability.
